UK Medtech To Leverage Accelerated Access Opportunity, Regardless Of The 'B' Word

 
• By Ashley Yeo
  
Andrew Witty (GSK)
Former GlaxoSmithKline CEO Andrew Witty will be chairing a body to select products for inclusionin the UK Accelerated Access Pathway.

More from United Kingdom

More from Europe